Medline (MDLN) Operating Expenses (2025 - 2026)

Medline (MDLN) reported Operating Expenses of $1.4 billion for Q1 2026, up 13.25% year-over-year from $1.3 billion in Q1 2025, and up 13.25% on a QoQ basis from $1.3 billion in Q1 2025.

Medline (MDLN) has 2 years of Operating Expenses data on file, last reported at $1.4 billion in Q1 2026.

  • Quarterly Operating Expenses rose 13.25% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 billion (changed N/A YoY) and the FY2025 annual result came in at $5.3 billion, up 9.86% from the prior year.
  • Operating Expenses grew to $1.4 billion in Q1 2026 per MDLN's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.4 billion in Q1 2026 and bottomed at $1.3 billion in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Intuitive Surgical 146.28 Bn 141.88 Bn 1.83 Bn 975.20 Mn
2 Becton Dickinson 41.14 Bn 40.13 Bn 2.15 Bn 4.62 Bn
3 Medline 29.16 Bn 35.00 Bn 1.84 Bn 1.42 Bn
4 Resmed 27.13 Bn 25.47 Bn 890.98 Mn 391.17 Mn
5 West Pharmaceutical Services 22.71 Bn 22.19 Bn 296.40 Mn 115.30 Mn
6 Solventum 13.26 Bn 13.26 Bn 1.10 Bn 1.02 Bn
7 Align Technology 12.22 Bn 11.16 Bn 736.59 Mn 594.63 Mn
8 Cooper Companies 11.79 Bn 11.66 Bn 695.20 Mn 434.50 Mn
9 Baxter International 9.47 Bn 7.42 Bn 891.00 Mn 867.00 Mn
10 Aptargroup 7.19 Bn 6.99 Bn 351.91 Mn 875.37 Mn

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 1.42 Bn
Mar 29, 2025 1.25 Bn